PubRank

Effect of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) on Conduction System Disease.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27367818)

Published in JAMA Intern Med on August 01, 2016

Authors

Thomas A Dewland1, Elsayed Z Soliman2, Barry R Davis3, Jared W Magnani3, Jose-Miguel Yamal4, Linda B Piller4, L Julian Haywood5, Alvaro Alonso6, Christine M Albert7, Gregory M Marcus8, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Collaborative Research Group

Author Affiliations

1: Knight Cardiovascular Institute, Oregon Health and Science University, Portland.
2: Department of Epidemiology and Prevention, Section of Cardiology, Wake Forest School of Medicine, Winston-Salem, North Carolina3Department of Internal Medicine, Section of Cardiology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
3: Section of Cardiovascular Medicine, Boston University School of Medicine, Boston, Massachusetts.
4: Department of Biostatistics, University of Texas School of Public Health, Houston.
5: Division of Cardiovascular Medicine, Keck School of Medicine, University of Southern California, Los Angeles.
6: Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis.
7: Center for Arrhythmia Prevention, Division of Preventive Medicine and Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
8: Section of Electrophysiology, Division of Cardiology, Department of Medicine, University of California, San Francisco.

Associated clinical trials:

Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) | NCT00000542

Articles by these authors ⇆

Atrial fibrillation incidence and risk factors in relation to race-ethnicity and the population attributable fraction of atrial fibrillation risk factors: the Multi-Ethnic Study of Atherosclerosis. Ann Epidemiol (2014) 0.98

American Heart Association's Life's Simple 7: Avoiding Heart Failure and Preserving Cardiac Structure and Function. Am J Med (2015) 0.94

Vitamin D and subclinical cerebrovascular disease: the Atherosclerosis Risk in Communities brain magnetic resonance imaging study. JAMA Neurol (2014) 0.94

Decade-long trends in atrial fibrillation incidence and survival: a community study. Am J Med (2014) 0.92

Height and risk of sudden cardiac death: the Atherosclerosis Risk in Communities and Cardiovascular Health studies. Ann Epidemiol (2013) 0.87

Association of 3 Different Antihypertensive Medications With Hip and Pelvic Fracture Risk in Older Adults: Secondary Analysis of a Randomized Clinical Trial. JAMA Intern Med (2016) 0.82

Genetic Investigation Into the Differential Risk of Atrial Fibrillation Among Black and White Individuals. JAMA Cardiol (2016) 0.79

Racial Differences in Atrial Fibrillation-Related Cardiovascular Disease and Mortality: The Atherosclerosis Risk in Communities (ARIC) Study. JAMA Cardiol (2016) 0.79

Association of amiodarone use with acute pancreatitis in patients with atrial fibrillation: a nested case-control study. JAMA Intern Med (2015) 0.75